Cargando…
Lymphoma risk in systemic lupus: effects of treatment versus disease activity
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467493/ http://dx.doi.org/10.1186/ar3950 |
_version_ | 1782245816241487872 |
---|---|
author | Clarke, AE Bernatsky, S Costenbader, KH Urowitz, MB Gladman, DD Fortin, PR Petri, M Manzi, S Isenberg, DA Rahman, A Wallace, D Gordon, C Peschken, C Dooley, MA Ginzler, EM Aranow, C Edworthy, SM Nived, O Jacobsen, S Ruiz-Irastorza, G Yelin, E Barr, SG Criswell, L Sturfelt, G Dreyer, L Blanco, I Gottesman, L Feldman, CH Ramsey-Goldman, R |
author_facet | Clarke, AE Bernatsky, S Costenbader, KH Urowitz, MB Gladman, DD Fortin, PR Petri, M Manzi, S Isenberg, DA Rahman, A Wallace, D Gordon, C Peschken, C Dooley, MA Ginzler, EM Aranow, C Edworthy, SM Nived, O Jacobsen, S Ruiz-Irastorza, G Yelin, E Barr, SG Criswell, L Sturfelt, G Dreyer, L Blanco, I Gottesman, L Feldman, CH Ramsey-Goldman, R |
author_sort | Clarke, AE |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3467493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34674932012-10-12 Lymphoma risk in systemic lupus: effects of treatment versus disease activity Clarke, AE Bernatsky, S Costenbader, KH Urowitz, MB Gladman, DD Fortin, PR Petri, M Manzi, S Isenberg, DA Rahman, A Wallace, D Gordon, C Peschken, C Dooley, MA Ginzler, EM Aranow, C Edworthy, SM Nived, O Jacobsen, S Ruiz-Irastorza, G Yelin, E Barr, SG Criswell, L Sturfelt, G Dreyer, L Blanco, I Gottesman, L Feldman, CH Ramsey-Goldman, R Arthritis Res Ther Meeting Abstract BioMed Central 2012 2012-09-27 /pmc/articles/PMC3467493/ http://dx.doi.org/10.1186/ar3950 Text en Copyright ©2012 Clarke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Abstract Clarke, AE Bernatsky, S Costenbader, KH Urowitz, MB Gladman, DD Fortin, PR Petri, M Manzi, S Isenberg, DA Rahman, A Wallace, D Gordon, C Peschken, C Dooley, MA Ginzler, EM Aranow, C Edworthy, SM Nived, O Jacobsen, S Ruiz-Irastorza, G Yelin, E Barr, SG Criswell, L Sturfelt, G Dreyer, L Blanco, I Gottesman, L Feldman, CH Ramsey-Goldman, R Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title | Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title_full | Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title_fullStr | Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title_full_unstemmed | Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title_short | Lymphoma risk in systemic lupus: effects of treatment versus disease activity |
title_sort | lymphoma risk in systemic lupus: effects of treatment versus disease activity |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467493/ http://dx.doi.org/10.1186/ar3950 |
work_keys_str_mv | AT clarkeae lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT bernatskys lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT costenbaderkh lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT urowitzmb lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT gladmandd lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT fortinpr lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT petrim lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT manzis lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT isenbergda lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT rahmana lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT wallaced lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT gordonc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT peschkenc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT dooleyma lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT ginzlerem lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT aranowc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT edworthysm lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT nivedo lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT jacobsens lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT ruizirastorzag lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT yeline lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT barrsg lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT criswelll lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT sturfeltg lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT dreyerl lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT blancoi lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT gottesmanl lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT feldmanch lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity AT ramseygoldmanr lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity |